ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPβ in CDH3 gene activation

Human Molecular Genetics

Volumn 19, Issue 13, 2010, Pages 2554-2566

  Albergaria, André ^a,b   Ribeiro, Ana Sofia ^b   Pinho, Sandra ^c   Milanezi, Fernanda ^b   Carneiro, Vítor ^d   Sousa, Bárbara ^b   Sousa, Sónia ^b   Oliveira, Carla ^b   Machado, José Carlos ^b,e   Seruca, Raquel ^b   Paredes, Joana ^b   Schmitt, Fernando ^b,e  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^e University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYTOKERATIN 14; CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; HISTONE H3; KI 67 ANTIGEN; P CADHERIN; PROGESTERONE RECEPTOR; VIMENTIN; ANTINEOPLASTIC AGENT; CADHERIN; CDH3 PROTEIN, HUMAN; DRUG DERIVATIVE; ESTRADIOL; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CYTOLOGY; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CADHERINS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 77954172745     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq134     Document Type: Article

References (46)

1. Goodwin, M. and Yap, A.S. (2004) Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton. J. Mol. Histol., 35, 839-844.
2. Conacci-Sorrell, M., Zhurinsky, J. and Ben-Ze'ev, A. (2002) The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest., 109, 987-991.
3. Paredes, J., Albergaria, A., Oliveira, J.T., Jeronimo, C., Milanezi, F. and Schmitt, F.C. (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin. Cancer Res., 11, 5869-5877.
4. Paredes, J., Correia, A.L., Ribeiro, A.S., Albergaria, A., Milanezi, F. and Schmitt, F.C. (2007) P-cadherin expression in breast cancer: a review. Breast Cancer Res., 9, 214.
5. Paredes, J., Stove, C., Stove, V., Milanezi, F., Van Marck, V., Derycke, L., Mareel, M., Bracke, M. and Schmitt, F. (2004) P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res., 64, 8309-8317.
6. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A. et al. (2000) Molecular portraits of human breast tumours. Nature, 406, 747-752.
7. Paredes, J., Milanezi, F., Viegas, L., Amendoeira, I. and Schmitt, F. (2002) P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch., 440, 16-21.
8. Paredes, J., Lopes, N., Milanezi, F. and Schmitt, F.C. (2007) P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch., 450, 73-80.
9. Paredes, J., Correia, A.L., Ribeiro, A.S., Milanezi, F., Cameselle-Teijeiro, J. and Schmitt, F.C. (2008) Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J. Clin. Pathol., 61, 856-862.
10. Ribeiro, A.S., Albergaria, A., Sousa, B., Correia, A.L., Bracke, M., Seruca, R., Schmitt, F.C. and Paredes, J. (2010) Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene, 29, 392-402.
11. Wheelock, M.J., Soler, A.P. and Knudsen, K.A. (2001) Cadherin junctions in mammary tumors. J. Mammary Gland Biol. Neoplasia, 6, 275-285.
12. Shimomura, Y., Wajid, M., Shapiro, L. and Christiano, A.M. (2008) P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle. Development, 135, 743-753.
13. Faraldo, M.M., Teuliere, J., Deugnier, M.A., Birchmeier, W., Huelsken, J., Thiery, J.P., Cano, A. and Glukhova, M.A. (2007) beta-Catenin regulates P-cadherin expression in mammary basal epithelial cells. FEBS Lett., 581, 831-836.
14. Milicic, A., Harrison, L.A., Goodlad, R.A., Hardy, R.G., Nicholson, A.M., Presz, M., Sieber, O., Santander, S., Pringle, J.H., Mandir, N. et al. (2008) Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res., 68, 7760-7768.
15. Tsutsumida, A., Hamada, J., Tada, M., Aoyama, T., Furuuchi, K., Kawai, Y., Yamamoto, Y., Sugihara, T. and Moriuchi, T. (2004) Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. Int. J. Oncol., 25, 1415-1421.
16. Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C.J., Cameron, J.L., Hruban, R.H. and Goggins, M. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res., 63, 3735-3742.
17. Sato, N., Maitra, A., Fukushima, N., van Heek, N.T., Matsubayashi, H., Iacobuzio-Donahue, C.A., Rosty, C. and Goggins, M. (2003) Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res., 63, 4158-4166.
18. Howell, A. (2000) Faslodex (ICI 182780). An oestrogen receptor downregulator. Eur. J. Cancer, 36 (Suppl 4), S87-S88.
19. Varshochi, R., Halim, F., Sunters, A., Alao, J.P., Madureira, P.A., Hart, S.M., Ali, S., Vigushin, D.M., Coombes, R.C. and Lam, E.W. (2005) ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. J. Biol. Chem., 280, 3185-3196.
20. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I. and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell, 129, 823-837.
21. Koch, C.M., Andrews, R.M., Flicek, P., Dillon, S.C., Karaoz, U., Clelland, G.K., Wilcox, S., Beare, D.M., Fowler, J.C., Couttet, P. et al. (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res., 17, 691-707.
22. Robinson, G.W., Johnson, P.F., Hennighausen, L. and Sterneck, E. (1998) The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev., 12, 1907-1916.
23. Seagroves, T.N., Krnacik, S., Raught, B., Gay, J., Burgess-Beusse, B., Darlington, G.J. and Rosen, J.M. (1998) C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev., 12, 1917-1928.
24. Zahnow, C.A. (2002) CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res., 4, 113-121.
25. Zahnow, C.A. (2009) CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev. Mol. Med., 11, e12.
26. Zahnow, C.A., Cardiff, R.D., Laucirica, R., Medina, D. and Rosen, J.M. (2001) A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res., 61, 261-269.
27. Milde-Langosch, K., Loning, T. and Bamberger, A.M. (2003) Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins. Breast Cancer Res. Treat., 79, 175-185.
28. Zahnow, C.A., Younes, P., Laucirica, R. and Rosen, J.M. (1997) Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer Inst., 89, 1887-1891.
29. Gamallo, C., Moreno-Bueno, G., Sarrio, D., Calero, F., Hardisson, D. and Palacios, J. (2001) The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod. Pathol., 14, 650-654.
30. Peralta Soler, A., Knudsen, K.A., Salazar, H., Han, A.C. and Keshgegian, A.A. (1999) P-cadherin expression in breast carcinoma indicates poor survival. Cancer, 86, 1263-1272.
31. Mello, M.L., Vidal, B.C., Russo, I.H., Lareef, M.H. and Russo, J. (2007) DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis. Mutat. Res., 617,1-7.
32. McKenna, N.J. and O'Malley, B.W. (2000) An issue of tissues: divining the split personalities of selective estrogen receptor modulators. Nat. Med., 6, 960-962.
33. McKenna, N.J. and O'Malley, B.W. (2001) Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann. N. Y. Acad. Sci., 949,3-5.
34. Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., Margulies, E.H., Weng, Z., Snyder, M., Dermitzakis, E.T., Thurman, R.E. et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
35. Pinskaya, M. and Morillon, A. (2009) Histone H3 lysine 4 di-methylation: a novel mark for transcriptional fidelity? Epigenetics, 4, 302-306.
36. Borley, A.C., Hiscox, S., Gee, J., Smith, C., Shaw, V., Barrett-Lee, P. and Nicholson, R.I. (2008) Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Breast Cancer Res., 10, R103.
37. Gee, J.M., Shaw, V.E., Hiscox, S.E., McClelland, R.A., Rushmere, N.K. and Nicholson, R.I. (2006) Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications. Endocr. Relat. Cancer, 13 (Suppl. 1), S77-S88.
38. Hutcheson, I.R., Knowlden, J.M., Jones, H.E., Burmi, R.S., McClelland, R.A., Barrow, D., Gee, J.M. and Nicholson, R.I. (2006) Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy. Endocr. Relat. Cancer, 13 (Suppl. 1), S89-S97.
39. Jones, H.E., Gee, J.M., Hutcheson, I.R., Knowlden, J.M., Barrow, D. and Nicholson, R.I. (2006) Growth factor receptor interplay and resistance in cancer. Endocr. Relat. Cancer, 13 (Suppl. 1), S45-S51.
40. Frasor, J., Chang, E.C., Komm, B., Lin, C.Y., Vega, V.B., Liu, E.T., Miller, L.D., Smeds, J., Bergh, J. and Katzenellenbogen, B.S. (2006) Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res., 66, 7334-7340.
41. Visram, H. and Greer, P.A. (2006) 17beta-estradiol and tamoxifen stimulate rapid and transient ERK activationin MCF-7 cells via distinct signaling mechanisms. Cancer Biol. Ther., 5, 1677-1682.
42. Cowell, L.N., Graham, J.D., Bouton, A.H., Clarke, C.L. and O'Neill, G.M. (2006) Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Oncogene, 25, 7597-7607.
43. Nicholson, R.I., Hutcheson, I.R., Hiscox, S.E., Knowlden, J.M., Giles, M., Barrow, D. and Gee, J.M. (2005) Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer. Endocr. Relat. Cancer, 12 (Suppl. 1), S29-S36.
44. Baxter, J., Sauer, S., Peters, A., John, R., Williams, R., Caparros, M.L., Arney, K., Otte, A., Jenuwein, T., Merkenschlager, M. et al. (2004) Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes. EMBO J., 23, 4462-4472.
45. Albergaria, A., Paredes, J., Sousa, B., Milanezi, F., Carneiro, V., Bastos, J., Costa, S., Vieira, D., Lopes, N., Lam, E.W. et al. (2009) Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res., 11, R40.
46. Matos, I., Dufloth, R., Alvarenga, M., Zeferino, L.C. and Schmitt, F. (2005) p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch., 447, 688-694.